Carbetocin
CAS No. 37025-55-1
Carbetocin ( —— )
产品货号. M20952 CAS No. 37025-55-1
卡贝缩宫素是一种产科化合物,用于控制产后出血和产后出血。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥405 | 有现货 |
|
| 10MG | ¥608 | 有现货 |
|
| 25MG | ¥1280 | 有现货 |
|
| 50MG | ¥2357 | 有现货 |
|
| 100MG | ¥3767 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Carbetocin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述卡贝缩宫素是一种产科化合物,用于控制产后出血和产后出血。
-
产品描述Carbetocin is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth.(In Vitro):Carbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).(In Vivo):Carbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile.Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat.
-
体外实验Carbetocin is an agonist with about 10-fold lower affinity for the oxytocin receptor but with significantly higher stability and a longer duration of action. Carbetocin has higher affinity to the chimeric E1 receptor and especially to each of the combinations of E1 with the other extracellular domains, i.e. chimeric receptors E13 (Ki=13 nM), E123 (Ki=56 nM), and E1234 (Ki=37 nM).
-
体内实验Carbetocin (2-20 mg/kg; i.p.) has a significant effect of treatment on the percent time spent climbing, swimming and immobile. Carbetocin (1, 10,100 μg/rat, i.c.v.) reveals a dose-dependent increase in the percent time spent swimming and a corresponding reduction in immobility following acute administration of 100 μg/rat. Animal Model:Male Sprague-Dawley rats weighing between 300 and 500 g Dosage:2, 6.4, 20 mg/kg Administration:IP; single dose Result:Increased climbing with 6.4 mg/kg and resulted in a significantly greater proportion of time spent swimming with 20 mg/kg.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Oxytocin Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number37025-55-1
-
分子量988.16
-
分子式C45H69N11O12S
-
纯度>98% (HPLC)
-
溶解度DMSO:31 mg/mL (31.37 mM)
-
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Theunissen F J Lester C Pujar Y V . Current research on carbetocin and implications for prevention of postpartum haemorrhage[J]. Reproductive Health 2018 15(S1):94-.
产品手册
关联产品
-
3-Hydroxybenzoic aci...
作为儿茶素饮食形成的三种主要代谢物之一在肠道微生物群中产生。它在生产苯甲酸乙二醇酯(用于粘合剂配方中的增塑剂)中的用途正在增加。
-
Rovazolac
Rovazolac是从来自专利WO2013130892A1中的肝脏x受体 (liver x receptor (LXR)) 调节剂。
-
Compound C108
Compound C108 是一种 G3BP2 抑制剂。Compound C108 也靶向应激颗粒相关蛋白、GTPase 激活蛋白 (SH3 结构域) 结合蛋白 2。Compound C108 显著抑制食管鳞状细胞癌 (ESCC) 细胞转移。
021-51111890
购物车()
sales@molnova.cn

